Document is current
Any future updates will be listed below
-
Authors
Mastall, Maximilian
Roth, Patrick
Bink, Andrea
Fischer Maranta, Angela
Läubli, Heinz
Hottinger, Andreas Felix
Hundsberger, Thomas
Migliorini, Denis
Ochsenbein, Adrian
Seystahl, Katharina
Imbach, Lukas
Hortobagyi, Tibor
Held, Leonhard
Weller, Michael
Wirsching, Hans-Georg
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33IC30-198794)
- License Information
-
More Information
Article History
Received: 9 December 2023
Accepted: 26 December 2023
First Online: 15 January 2024
Declarations
:
: The conduct of this clinical trial was approved by the Swiss Association of Research Ethics Committees (Business Administration System for Ethics Committees (BASEC) ID: 2022-01877, lead ethics committee: cantonal ethics committee Zurich, approval date: 20.12.2022) and by the swiss federal authorities (Swiss Agency of Therapeutic Products, Swissmedic No. 701474). Written informed consent for participation in this clinical trial is required from all study participants.
: Not applicable.
: The authors declare no competing interests.
